Literature DB >> 28225746

Atypical Antipsychotics and the Risk of Falls and Fractures Among Older Adults: An Emulation Analysis and an Evaluation of Additional Confounding Control Strategies.

Darmendra Ramcharran1, Hong Qiu, Martijn J Schuemie, Patrick B Ryan.   

Abstract

PURPOSE: The aim of this study was to investigate the risk of falls and fractures among older adults receiving atypical antipsychotics.
METHODS: An emulation analysis of a previously published study was performed using the US Truven MarketScan Medicare Supplemental database (MDCR). In addition, modified analyses were implemented to evaluate alternative confounding control strategies that (1) included all covariates used to fit propensity score models in outcome models and (2) required patients to have a mental health condition diagnosis and a health care visit within 90 days prior to the index date.
FINDINGS: The MDCR emulation analyses yielded similar results as the previous study. For the previous study and our emulation analysis, the results were: nonvertebral osteoporotic fractures (odds ratio [OR], 1.51; 95% confidence interval [CI], 1.41-1.60; and OR, 1.49; 95% CI, 1.37-1.63, respectively), hip fractures (OR, 1.67; 95% CI, 1.53-1.81; and OR, 1.59; 95% CI, 1.43-1.77, respectively), any fracture (OR, 1.29; 95% CI, 1.24-1.34; and OR, 1.32; 95% CI, 1.23-1.41, respectively), and falls (OR, 1.54; 95% CI, 1.47-1.61; and OR, 1.45; 95% CI, 1.11-1.89, respectively). However, in modified analyses, no associations were significant. The primary change that resulted in the attenuation of associations was the requirement for patients to have a mental health condition diagnosis and a health care visit prior to the index date.
CONCLUSIONS: Our MDCR emulation analysis yielded similar results as a previous study; however, in modified analyses, the associations between fractures and falls and atypical antipsychotics were no longer significant. The contrast of results between the emulation and modified analyses may be due to the analytic approach used to compare patients (and potential confounding by indication). Further research is warranted to evaluate these associations.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28225746     DOI: 10.1097/JCP.0000000000000647

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  4 in total

1.  How Confident Are We about Observational Findings in Healthcare: A Benchmark Study.

Authors:  Martijn J Schuemie; M Soledad Cepeda; Marc A Suchard; Jianxiao Yang; Yuxi Tian; Alejandro Schuler; Patrick B Ryan; David Madigan; George Hripcsak
Journal:  Harv Data Sci Rev       Date:  2020-01-31

2.  CYP2D6-inhibiting drugs and risk of fall injuries after newly initiated antidepressant and antipsychotic therapy in a Swedish, register-based case-crossover study.

Authors:  Marja-Liisa Dahl; Karin Leander; Max Vikström; Clara Frumerie; Sofia Nordenmalm; Jette Möller; Karin Söderberg-Löfdal
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

3.  Improving reproducibility by using high-throughput observational studies with empirical calibration.

Authors:  Martijn J Schuemie; Patrick B Ryan; George Hripcsak; David Madigan; Marc A Suchard
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2018-09-13       Impact factor: 4.226

4.  Exposure to risperidone versus other antipsychotics and risk of osteoporosis-related fractures: a population-based study.

Authors:  E Clapham; R Bodén; J Reutfors; T Svensson; D Ramcharran; H Qiu; H Kieler; S Bahmanyar
Journal:  Acta Psychiatr Scand       Date:  2019-10-11       Impact factor: 6.392

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.